Skip to search formSkip to main contentSkip to account menu

mofezolac

Known as: (3,4-bis(4-methoxyphenyl)-5-isoxazolyl)acetic acid, (3,4-di-(4-methoxyphenyl)-5-isoxazolyl)acetic acid, 3,4-DMPIAA 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
We demonstrated recently that mofezolac, a cyclooxygenase‐1 (COX‐1) selective inhibitor, suppresses the development of… 
Highly Cited
2004
Highly Cited
2004
As with cyclooxygenase (COX)‐2, genetic disruption of COX‐1 gene or pharmacologic inhibition of its activity has been shown to… 
Highly Cited
2003
Highly Cited
2003
Nonsteroidal anti-inflammatory drugs are known to suppress the occurrence and progression of malignancies such as colorectal… 
Highly Cited
2002
Highly Cited
2002
Cyclooxygenase (COX)-2, one enzyme isoform responsible for producing prostanoids from arachidonic acid, contributes to colon…